IOL Chemicals and Pharmaceuticals Limited
Stock Forecast, Prediction & Price Target

IOL Chemicals and Pharmaceuticals Limited Financial Estimates

IOL Chemicals and Pharmaceuticals Limited Revenue Estimates

IOL Chemicals and Pharmaceuticals Limited EBITDA Estimates

IOL Chemicals and Pharmaceuticals Limited Earnings per Share Estimates

Passed Analyst forecast
Metric 3/31/2021 3/31/2022 3/31/2024 3/31/2026
Revenue
 
% change YoY
₹19.46B
 
N/A
₹21.68B
 
11.41%
₹21.32B
 
-1.64%
Avg: ₹27.14B
Low: ₹26.43B
High: ₹27.86B
avg. 27.28%
Net Income
 
% change YoY
₹4.44B
 
N/A
₹1.67B
 
-62.28%
₹1.34B
 
-19.82%
Avg: ₹2.31B
Low: ₹2.23B
High: ₹2.40B
avg. 72.48%
EBITDA
 
% change YoY
₹6.16B
 
N/A
₹2.85B
 
-53.65%
₹2.60B
 
-8.71%
Avg: ₹5.32B
Low: ₹5.18B
High: ₹5.46B
avg. 104.37%
EPS
 
% change YoY
$76.21
 
N/A
$28.56
 
-62.52%
$22.9
 
-19.81%
Avg: $39.5
Low: $38
High: $41
avg. 72.48%
Operating Expenses
 
% change YoY
₹2.68B
 
N/A
₹3.55B
 
32.24%
₹2.20B
 
-38.09%
Avg: ₹1.42B
Low: ₹1.38B
High: ₹1.45B
avg. -35.48%

FAQ

What is IOL Chemicals and Pharmaceuticals Limited stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 72.48% in 2026-2026.

We have gathered data from 2 analysts. Their low estimate is 2.23B, average is 2.31B and high is 2.40B.

What is IOL Chemicals and Pharmaceuticals Limited stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 27.28% in 2026-2026.

We have gathered data from 2 analysts. Their low revenue estimate is ₹26.43B, average is ₹27.14B and high is ₹27.86B.

What is IOL Chemicals and Pharmaceuticals Limited stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 72.48% in 2026-2026.

We have gathered data from 2 analysts. Their low earnings per share estimate is $38, average is $39.5 and high is ₹41.